Treatment of paediatric Hodgkin's disease. a balance of risks (Q34548570)

2 August 2017

1 reference

title

Treatment of paediatric Hodgkin's disease. a balance of risks (English)

1 reference

2 August 2017

Thomson AB

1

1 reference

2 August 2017

Wallace WH

series ordinal

2

1 reference

2 August 2017

publication date

1 March 2002

1 reference

European Journal of Cancer

2 August 2017

published in

1 reference

2 August 2017

volume

38

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

468-477

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

2 August 2017

1 reference

7 January 2021

Effect of spinal irradiation on growth

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Gonadal function after combination chemotherapy for Hodgkin's disease in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Cardiac disease following treatment of Hodgkin's disease in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Second malignant tumors following treatment during childhood and adolescence for cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Incidence of malignant disease in childhood: a 24-year review of the Manchester Children's Tumour Registry data

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Lymphoma of the mediastinum and neck: evaluation with Ga-67 imaging and CT correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Twenty years of MOPP therapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

The balance between cure and late effects in childhood Hodgkin's lymphoma: the experience of the German-Austrian Study-Group since 1978. German-Austrian Pediatric Hodgkin's Disease Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Assessment of the stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin's disease: Eastern Cooperative Oncology Group pilot study E1492

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

EPIC: an effective low toxicity regimen for relapsing lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

A limited role for VEEP (vincristine, etoposide, epirubicin, prednisolone) chemotherapy in childhood Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Risk factors for thyroid abnormalities after neck irradiation for childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Endocrine deficit after fractionated total body irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Effect of abdominal irradiation on growth in boys treated for a wilms′ tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Gonadal damage from chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Aspermia following lower truncal irradiation in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Vulnerability of the human Leydig cell to radiation damage is dependent upon age.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Gonadal function in young patients successfully treated for Hodgkin disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Gonadal function following chemotherapy for childhood Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Ovarian failure following abdominal irradiation in childhood: natural history and prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Ovarian failure following abdominal irradiation in childhood: the radiosensitivity of the human oocyte

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

The long-term effects of x irradiation in patients treated for metropathia haemorrhagica

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Early menopause in long-term survivors of cancer during adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Abdominal irradiation in childhood; the potential for pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Pregnancy outcome after treatment for acute lymphoblastic leukemia during childhood or adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Late cardiac effects of therapeutic mediastinal irradiation. Assessment by echocardiography and radionuclide angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Second cancers following pediatric Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Leukemia following Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Leukemia after therapy with alkylating agents for childhood cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Breast cancer and other second neoplasms after childhood Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Breast cancer after treatment of Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Sex differences in risk of second malignant tumours after Hodgkin's disease in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Phase III, large-scale chemoprevention trials. Approach to chemoprevention clinical trials and phase III clinical trial of tamoxifen as a chemopreventive for breast cancer--the US National Cancer Institute experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Fertility preservation for children treated for cancer (1): scientific advances and research dilemmas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Fertility preservation for children treated for cancer (2): ethics of consent for gamete storage and experimentation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

BFS Recommendations for Good Practice on the Storage of Ovarian and Prepubertal Testicular Tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

Conference consensus statement: ethical and research dilemmas for fertility preservation in children treated for cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900335-5

7 January 2021

10.1016/S0959-8049(01)00335-5

Identifiers

DOI

1 reference

2 August 2017

1 reference